CLINICAL_TRIALS
trial_result
· 2015-12-07
Clinical Trial Update: Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD) [Phase 3]
Summary
A Phase 3 feasibility study evaluating PH94B nasal spray for acute treatment of social anxiety disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pherin Pharmaceuticals, Inc. | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED